TrialBMC cancer2022

Multicentre, randomised, open-label, parallel-group, clinical phase II study to evaluate immunonutrition in improving efficacy of immunotherapy in patients with metastatic non-small cell lung cancer, undergoing systematic nutritional counseling.

Riccardo Caccialanza et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.